Planisware Updates Share Dealings for October 2025 Activities

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

A Bold Fashion Statement: NotHappening Launches Today, a remarkable fashion phenomenon has emerged, capturing the imagination of enthusiasts and critics alike. NotHappening, a daring new brand, has made its grand entrance into the world of luxury streetwear, and it's more than just a fashion label; it's a commentary on contemporary culture and the pervasive influence of...

Navigating Hormone Evaluations with Clarity In the labyrinth of healthcare, figuring out what's crucial for your well-being can be a tangled mess. Today's focus is unraveling the often-overlooked world of hormone evaluations. It's not just about popping pills based on hunches—it's about getting a well-rounded picture of your health. Annette Asper from Rewritten Klinik...

Radix Showcases Innovations in Digital Twin Technology Radix is all set to unveil its groundbreaking innovations in asset integrity and energy transition at the renowned Future Digital Twin & Generative AI Conference. Hosted at the Energy Transition Campus in Amsterdam, this event is a gathering of industry experts and technology leaders aimed at tackling significant...

Genmab's Epcoritamab Combination Therapy Approved Company Announcement Genmab A/S (NASDAQ: GMAB) has achieved an important milestone with the FDA's approval of Epcoritamab, marketed as EPKINLY®, combined with rituximab and lenalidomide, a trio set to offer hope to adults suffering from relapsed or refractory follicular lymphoma (R/R FL). Pivotal Phase 3 Study Results The...

EchoStar Corporation Financial Results Overview EchoStar Corporation (NASDAQ: SATS) has released its impressive financial results for the recently concluded quarter. The results indicate a robust performance, emphasizing growth across several key business areas. The company has focused on enhancing its operational efficiencies while ensuring that customer experiences are...